HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Therapeutic use of a peptide fraction derived from bovine factor VIII in epistaxis in children].

Abstract
The results obtained in patients suffering from essential epistaxis in paediatric age using a peptide fraction derived from the enzymatic hydrolysis of bovine factor VIII (VUEFFE-Baldacci) are reported. Carbazochrome sodium sulphate was employed for comparison purposes. Vueffe is effective in reducing haemorrhagic episodes without modifying the laboratory parameters investigated.
AuthorsV Tarantino, M Stura, M Cingolani
JournalMinerva pediatrica (Minerva Pediatr) Vol. 41 Issue 11 Pg. 549-51 (Nov 1989) ISSN: 0026-4946 [Print] Italy
Vernacular TitleUtilizzaione terapeutica di una frazione peptidica derivata dal fattore VIII bovino nelle epistassi in età pediatrica.
PMID2533661 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Adrenochrome
  • carbazochrome
  • Factor VIII
Topics
  • Adolescent
  • Adrenochrome (analogs & derivatives, therapeutic use)
  • Child
  • Drug Evaluation
  • Epistaxis (drug therapy)
  • Factor VIII (therapeutic use)
  • Female
  • Humans
  • Male
  • Randomized Controlled Trials as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: